FBXO31 and prostate carcinoma: FBXO31, the member of protein-ubiquitin ligase, activates ERK- and suppresses PI3K-AKT-mediated signaling pathways in prostate cancer by promoting the degradation of DUSP6 (Duan et al., 2021).